×
Back to Agenda
S23 : New Normal for Patients: Future Changes Brought by the Revision of the Pharmaceutical and Medical Device Act
Session Chair(s)
Kiyohito Kuno, PHD
Executive Director, Regulatory Affairs, MSD, Japan
Speaker(s)
Daisuke Sato, MSC
Section Chief, Pharmaceutical Evaluation Division,, Ministry of Health, Labour and Welfare (MHLW), Japan
Takayuki Imaeda, MPHARM, MS
Head of Regulatory Sciences, Pfizer R&D Japan, Japan
Yoshiyuki Majima, PHD
President, Pancreatic Cancer Action Network Japan, Japan
Have an account?